Detalles de la búsqueda
1.
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions.
Int J Gynecol Cancer
; 33(11): 1733-1742, 2023 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931976
2.
Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery.
Int J Gynecol Cancer
; 29(7): 1156-1163, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31352365
3.
Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer.
Int J Gynecol Cancer
; 27(8): 1774-1782, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28708786
4.
Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary.
Int J Gynecol Cancer
; 24(9 Suppl 3): S26-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25126954
5.
Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting.
Gynecol Oncol Rep
; 51: 101332, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362364
6.
Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells.
Int J Cancer
; 133(5): 1143-52, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23436651
7.
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer.
Am J Clin Oncol
; 46(7): 314-322, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37106485
8.
Omitting lymphadenectomy in patients with endometrial cancer.
Cancer
; 123(2): 197-199, 2017 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28067947
9.
Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells.
Am J Obstet Gynecol
; 206(3): 253.e1-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22206747
10.
Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States.
Curr Med Res Opin
; 38(11): 1935-1945, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975577
11.
Germ cell tumors: Treatment consensus across all age groups through MaGIC [Malignant Germ Cell International Collaborative].
Cancer
; 122(2): 181-3, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26485495
12.
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.
Gynecol Oncol
; 121(3): 455-61, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21414654
13.
Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study.
Gynecol Oncol
; 119(3): 444-50, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20846715
14.
The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer.
J Surg Oncol
; 101(4): 334-43, 2010 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20187069
15.
Cardiac metastasis from poorly differentiated carcinoma of the cervix: a case report.
J Reprod Med
; 55(1-2): 78-80, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20337214
16.
The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
Gynecol Oncol
; 115(3): 377-81, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19800107
17.
Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer.
Am J Obstet Gynecol
; 200(5): 516.e1-6, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19268879
18.
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
Int J Radiat Oncol Biol Phys
; 66(5): 1356-65, 2006 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16757127
19.
Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy.
PLoS One
; 11(1): e0147145, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26788855
20.
Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients.
Int J Radiat Oncol Biol Phys
; 61(4): 1078-86, 2005 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15752887